What do we already know about this topic?

• Insulin-treated patients with type 2 diabetes (T2D) are at risk of hypoglycemia, which is associated with an increased risk of cardiovascular disease and mortality.
• Hypoglycemia is linked to blood coagulation abnormalities, endothelial dysfunction, and inflammation.¹
• Night-time hypoglycemia episodes tend to be longer than those occurring during waking, and may not be recognized by the patient.^2-4

How was this study conducted?

• This study investigated the association between episodes of hypoglycemia, glycemic variability, and cardiac arrhythmias in a real-life setting.
• 21 insulin-treated patients with T2D were included for a 1-year observational study employing continuous glucose monitoring and implantable cardiac monitors (ICMs).